By Rishika Sadam HYDERABAD (Reuters) - India's food safety regulator said on Thursday it had ordered testing and inspections at all companies making spice mixes, widening an investigation into the...
By Diana Novak Jones (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury...
(Reuters) -U.S. drugmaker Regeneron Pharmaceuticals Inc missed Wall Street estimates for quarterly profit on Thursday, hurt by softer sales of its blockbuster eye drug Eylea due to reduction in wholesaler...
By Bhanvi Satija (Reuters) -Cigna Group raised its annual profit forecast on Thursday, helped by lower-than-expected medical costs and strength in its pharmacy benefit management unit. The health insurer's second...
(Reuters) - Medical device maker Baxter International raised its annual profit forecast and beat quarterly estimates on Thursday, banking on strong demand for its infusion pumps and dialysis products. Investor...
By Tom Polansek and Julie Steenhuysen CHICAGO (Reuters) - Bird flu likely circulated in U.S. dairy cows on a limited basis for about four months before federal officials confirmed the...
By Lisa Baertlein, Julie Steenhuysen and Tom Polansek LOS ANGELES/CHICAGO (Reuters) - U.S. sellers of raw milk appear undeterred by federal health warnings for consumers to avoid drinking unpasteurized milk...
(Reuters) - DaVita raised its annual profit forecast on Thursday banking on strong demand for its kidney dialysis services, sending its shares up 3.7% in trading after the bell. The...
By Deena Beasley (Reuters) -Amgen on Thursday said it was very encouraged after completing an interim analysis of its mid-stage study of experimental weight-loss drug MariTide and will no longer...
(Reuters) - Illumina reiterated its 2024 revenue forecast on Thursday, expecting continued weak demand from its customers such as medical research labs and hospitals. The San Diego, California-based company, whose...
SAO PAULO (Reuters) - Brazil declared itself on Thursday as free of foot and mouth disease without vaccination, and will request World Organization for Animal Health (WOAH) to recognize that...
By Bhanvi Satija and Patrick Wingrove (Reuters) -Pfizer lifted its annual earnings forecast on Wednesday and reported a first-quarter profit above Wall Street estimates, boosted by cost cutting efforts and...
By Julie Steenhuysen and Tom Polansek CHICAGO (Reuters) -Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration...
(Reuters) -Emergent BioSolutions said on Wednesday that it would cut about 300 jobs across all areas of the company and shut down several manufacturing facilities as part of a restructuring...
By Brad Brooks (Reuters) -The Arizona Senate voted on Wednesday to repeal the state's 1864 ban on abortion, which could otherwise have taken effect within weeks. The repeal was passed...
By Ahmed Aboulenein and Zeba Siddiqui WASHINGTON (Reuters) - Hackers who breached UnitedHealth's tech unit in February potentially stole a third of Americans' data, the largest U.S. health insurer's CEO...
By Brendan Pierson (Reuters) -A federal judge has struck down parts of a North Carolina law restricting patients' access to the abortion pill mifepristone, which has become the subject of...
By Nandita Bose JACKSONVILLE, Florida (Reuters) -U.S. Vice President Kamala Harris sought to blame Republican candidate Donald Trump for Florida's six-week abortion ban that took effect on Wednesday, saying his...
By Dietrich Knauth and Mike Spector NEW YORK(Reuters) -Johnson & Johnson said on Wednesday it is moving forward with a $6.48 billion proposed settlement of tens of thousands of lawsuits...
By Tanay Dhumal (Reuters) -Shares of cannabis companies surged on Tuesday afternoon after the U.S. Department of Justice (DoJ) moved to reclassify marijuana as a less dangerous drug. U.S.-listed shares...
By Amina Niasse NEW YORK (Reuters) - Almost all U.S. hospitals were hurt financially by the cyberattack on United Health Group’s Change Healthcare unit earlier this year, according to a...
By Bhanvi Satija and Patrick Wingrove (Reuters) -Explosive demand and increased manufacturing capacity for Eli Lilly's weight-loss drug Zepbound drove the company to raise its annual sales forecast by $2...
By Mrinalika Roy (Reuters) - The U.S. Justice Department is moving to make marijuana use a less serious federal crime with a proposal to reclassify the drug as on par...
By Brendan Pierson (Reuters) -The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in...
By Sruthi Narasimha Chari (Reuters) -The U.S. Food and Drug Administration (FDA) has approved the granule formulation of Neurocrine Biosciences' Ingrezza drug to treat movement disorders associated with Huntington's disease...
By Jeff Mason, Pratik Jain and Sarah N. Lynch WASHINGTON (Reuters) - The U.S. Justice Department on Tuesday moved to make marijuana use a less serious federal crime, taking a...
(Adds media packaging code) (Reuters) - Stryker Corp lifted its full-year profit forecast on Tuesday, owing to resilient demand for the company's medical devices and implants. The joint-implant maker now...
By Brendan Pierson (Reuters) - Health insurance plans run by U.S. states must cover gender-affirming surgeries for transgender people, a U.S. appeals court ruled on Monday. The 8-6 opinion from...
By Tom Polansek CHICAGO (Reuters) -The U.S. government said on Monday it is collecting samples of ground beef at retail stores in states with outbreaks of bird flu in dairy...
By Brendan Pierson (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices...
